• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
exit sign
Pharma

Legend Biotech CEO resigns; search underway for replacement

Legend has been under pressure from concerns over potential competition to Carvykti, as well as geopolitical risks given its ties to China.
Angus Liu Jul 27, 2026 9:32am
Advancing mCSPC Treatment A Closer Look at ADT  Darolutamide with Dr Rana McKay

Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay

Brought to you by Bayer
brain

FDA approves Otsuka’s first-in-class ADHD drug Simtriyo

Jul 27, 2026 12:42pm
The CSO Model Is Endangered Heres How Contract Field Organizations Must Evolve to Survive

The CSO Model Is Endangered. Here’s How to Evolve.

Brought to you by Mix Talent
Traffic light go start restart green light

After 3 CRLs, FDA approves Outlook's AMD drug Lytenava

Jul 27, 2026 11:51am
Sarepta Sarepta Therapeutics

Sarepta taps AbbVie vet Severino to take over for retiring CEO

Jul 27, 2026 11:36am
More News

AZ leans on cancer, rare disease muscle in solid Q2

Jul 27, 2026 10:21am

Durable IBD remission remains an unmet need: survey

Jul 24, 2026 2:07pm

Peptide adcomm Day 2: Emideltide fails to make grade in vote

Jul 24, 2026 2:00pm

The Oral GLP-1 Tracker: Obesity prescriptions jump

Jul 24, 2026 11:00am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings